NORMAL AND ABNORMAL FIBRINOLYSIS

被引:28
作者
KERNOFF, PBA [1 ]
MCNICOL, GP [1 ]
机构
[1] UNIV LEEDS,GEN INFIRM,DEPT MED,LEEDS LS1 3EX,ENGLAND
关键词
D O I
10.1093/oxfordjournals.bmb.a071442
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:239 / 244
页数:6
相关论文
共 87 条
[1]  
ABERG M, 1975, PROGR CHEMICAL FIBRI, V1, P121
[2]   CHLORPROPAMIDE AND FIBRINOLYTIC-ACTIVITY IN MATURITY ONSET DIABETES-MELLITUS [J].
ALEXANDER, WD ;
WENSLEY, RT ;
PRICE, G ;
HARTOG, M .
POSTGRADUATE MEDICAL JOURNAL, 1976, 52 (607) :251-253
[3]   MECHANISM OF CLOT DISSOLUTION BY PLASMIN [J].
ALKJAERSIG, N ;
FLETCHER, AP ;
SHERRY, S .
JOURNAL OF CLINICAL INVESTIGATION, 1959, 38 (07) :1086-1095
[4]   LOW VASCULAR FIBRINOLYTIC-ACTIVITY IN OBESITY [J].
ALMER, LO ;
JANZON, L .
THROMBOSIS RESEARCH, 1975, 6 (02) :171-175
[5]  
ALMER LO, 1975, J MED, V6, P351
[6]   PLASMIN-ANTIPLASMIN COMPLEX AS A RESERVOIR OF FIBRINOLYTIC ENZYME [J].
AMBRUS, CM ;
MARKUS, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1960, 199 (03) :491-494
[7]   THROMBOSIS AND ORAL-CONTRACEPTIVES - POSSIBLE PREDISPOSITION [J].
ASTEDT, B ;
ISACSON, S ;
NILSSON, IM ;
PANDOLFI, M .
BRITISH MEDICAL JOURNAL, 1973, 4 (5893) :631-634
[8]   PLASMINOGEN PROACTIVATOR-ACTIVATOR SYSTEM IN HUMAN-BLOOD EFFECTIVE IN ABSENCE OF HAGEMAN-FACTOR [J].
ASTRUP, T ;
ROSA, AT .
THROMBOSIS RESEARCH, 1974, 4 (04) :609-613
[9]  
ASTRUP T, 1966, FED PROC, V25, P42
[10]  
ASTRUP T, 1975, PROTEASES BIOL CONTR, P343